NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0110
0.00 (0.00%)
At close: Nov 5, 2026
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $1.44 million as of November 6, 2026. It is the 48,714th most valuable company in the world and the 6,531st biggest in the United States. Its market cap has decreased by 42.25% in one year.
Market Cap
1.44M
Enterprise Value
39.62M
Revenue
n/a
Global Rank
Country Rank
#6,531 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 1.44M, a decrease of -99.58%. That is a compound annual growth rate of -81.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 1.44M | -76.90% |
| Dec 31, 2025 | 6.22M | -73.65% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CASI Pharmaceuticals | 2.06M |
| Emmaus Life Sciences | 1.92M |
| Vaxxinity | 1.90M |
| Agentix | 1.60M |
| Enzolytics | 1.45M |
| Avenue Therapeutics | 1.32M |
| inTerra Resources | 1.30M |
| Halberd | 1.29M |